Acute Ischemic Stroke Diagnosis Market Size, Share, Growth, Trends and Forecast 2033

"The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company presents an extensive market research report on the Acute Ischemic Stroke Diagnosis Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.

Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing all necessary data for thriving in the industry. This report market research offers a comprehensive perspective, including an in-depth analysis of the present and future scenarios within the industry.

Market Sizing:

The acute ischemic stroke diagnosis market size has grown strongly in recent years. It will grow from $2.14 billion in 2023 to $2.31 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rise in cardiovascular risk factors, telemedicine adoption, establishment of stroke centers, increased aging population, development of thrombolytic therapies.

The acute ischemic stroke diagnosis market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to remote monitoring technologies, patient-centric healthcare models, integration of wearable devices, point-of-care testing devices, expansion of mobile stroke units. Major trends in the forecast period include advancements in imaging technologies, advancements in artificial intelligence, genetic and biomarker product innovations, blockchain for data security, integration of augmented reality.

Request for free sample report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12150&type=smp

Key Market Players:

Major companies operating in the acute ischemic stroke diagnosis market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Philips Healthcare, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Genentech Inc., Nihon Kohden Corporation, Neusoft Medical Systems Co. Ltd., Penumbra Inc., Insera Therapeutics LLC, MicroVention Inc., FUJIFILM Medical Systems, Canon Medical Systems Corporation, Silk Road Medical Inc., Samsung Neurologica Corporation, Mentice AB, NICO Corporation, Imperative Care Inc., Olea Medical, NovaSignal Corporation, iSchemaView Inc., Hyperfine Research Inc., Perfuze Ltd.

Market Drivers:

The rising prevalence of acute ischemic stroke cases is expected to propel the growth of the acute ischemic stroke diagnosis market going forward. Acute ischemic stroke refers to a severe medical emergency brought on by poor blood supply to the brain, which causes brain cell destruction. Early diagnosis of acute ischemic stroke will aid in treatment and reduce brain damage and other consequences resulting from the stroke. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, stroke deaths increased from 38.8 per 100,000 in 2020 to 41.1 per 100,000 in 2021. Further, in the United States, there are more than 795,000 strokes per year; 610,000 are first-time strokes and ischemic strokes, in which blood flow to the brain is impeded, account for around 87% of all strokes. Therefore, the rising prevalence of acute ischemic stroke cases is driving the growth of the acute ischemic stroke diagnosis market.

Learn More About The Market Report -
https://www.thebusinessresearchcompany.com/report/acute-ischemic-stroke-diagnosis-global-market-report

The acute ischemic stroke diagnosis market covered in this report is segmented
1) By Diagnostic Type: Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography (ECG), Echocardiography, Other Diagnostics
2) By Surgery Type: Carotid Endarterectomy, Angioplasty, Endovascular Mechanical Thrombectomy
3) By Application: Tissue Plasminogen Activator (TPA), Anticoagulant, Antiplatelet, Antihypertensive

The report answers the following questions:
What are the primary factors propelling the market during the projected period?

In which region is the most substantial growth expected?

Which trend will take center stage in the upcoming period?

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.